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The proportion of positive Leptospira microscopic
agglutination tests for 23,005 dogs significantly increased
from 2002 to 2004 (p<0.002) regardless of the positive cut-
off titer used and was highest (p<0.05) for serovars
Autumnalis and Grippotyphosa. The strongest positive
serologic correlation (r = 0.72) was between serovars
Autumnalis and Pomona.
L
eptospirosis is a zoonotic disease with reservoirs in
companion animals, livestock, and wild animals. More
than 200 Leptospira serovars have been identified (1).
Dogs are considered maintenance hosts for serovar
Canicola, incidental hosts for other serovars, and are a
potential source of infection for pet owners (2). Bivalent
leptospirosis bacterins containing serovars Canicola and
Icterohaemorrhagiae have been available for use in dogs
since the 1960s. Despite use of these bacterins, canine lep-
tospirosis diagnosed at US veterinary teaching hospitals
has increased since 1990 (3). Case reports have attributed
canine infection primarily to serovars Grippotyphosa,
Pomona, Bratislava, and Autumnalis (4–6). Although
human leptospirosis ceased to be a notifiable disease in
1994, outbreaks are still reported and infecting serovars in
humans are antigenically related to the emerging serovars
in dogs (7,8). 
The referent method for serologic diagnosis of lep-
tospirosis is the microscopic agglutination test (MAT). The
serovar in which agglutination is detected at the highest
dilution of serum is indicative of the infective serogroup,
but cross-reactions between serovars is common (9).
Laboratory databases are potentially useful for surveil-
lance of zoonotic pathogens. Therefore, we determined the
percentage of positive MAT results for leptospirosis for
each seropositive state by using sera from dogs with sus-
pected clinical leptospirosis that were submitted to a
nationwide veterinary diagnostic laboratory. We also eval-
uated the statistical correlation of seropositivity between
different serovars.
The Study
The results of all leptospirosis MATs for dogs from
January 2002 through December 2004 were obtained elec-
tronically from Antech Diagnostic Veterinary Laboratory
(Los Angeles, CA, USA). Antech provides laboratory serv-
ices to >18,000 US veterinary hospitals. The 7 Leptospira
serovars included in the MATs were Canicola,
Grippotyphosa, Icterohaemorrhagiae, Hardjo, Pomona,
Autumnalis, and Bratislava. MAT results for each serovar
were reported as the highest dilution of serum (1:100,
1:200, 1:400, 1:800, 1:1,600, 1:3,200, 1:6,400, or
>1:12,800) at which >50% agglutination of organisms
occurred when compared with a control suspension.
Calculation of seropositivity was performed separately
by using cutoff titers of >400, >800, or >1,600. The per-
centage of seropositive test results for each serovar was
calculated both as the number of positive test results divid-
ed by the total number of tests performed and by the total
number of positive test results with 95% confidence limits.
The percentage of seropositive MAT results was calculat-
ed by state and year. Proportions for categoric variables
were compared by using the χ2 test for independence. A
rank from 1 to 9 was assigned based on the serum dilution
results. If 2 serovars had equivalent titers on a MAT for a
dog, both serovars received the same rank score appropri-
ate for that dilution. Correlation of seropositivity between
all 2-way comparisons of serovars was by Spearman rank
correlation. All calculations were performed by using SAS
version 9.1.3 statistical software (SAS, Cary, NC, USA),
and a p value >0.05 was considered significant. Tests that
used paired sera from the same dog or tests repeated on the
same dog at a different time could not be identified
because patient identifiers were not included in the data-
base. Therefore, a few individual dogs could have con-
tributed >1 test to the dataset, but this possibility was
considered uncommon.
During the study, 23,005 serum samples were submit-
ted for a leptospirosis MAT, and ≈23,000 tests were per-
formed for each of 5 serovars, namely Canicola,
Grippotyphosa, Icterohaemorrhagiae, Hardjo, and Pomona
(Table). Laboratory testing for serovars Autumnalis and
Bratislava was initiated in 2003, and ≈11,600 tests were
performed for each of these 2 serovars. The percentage of
MATs that were positive significantly increased from 2002
to 2004 by using cutoff titers >400 (p<0.002), >800
(p<0.0001), or >1,600 (p<0.0001). At these 3 cutoff titers,
the percentage of positive MAT results was greatest for
serovars Autumnalis (9.1%, 6.5%, and 4.7%, respectively)
and Grippotyphosa (6.4%, 4.9%, and 4.0%, respectively).
The proportion of positive MAT results attributable to
serovars Canicola or Icterohaemorrhagiae declined as the
cutoff titer increased, while it generally increased for
serovars Autumnalis, Bratislava, Grippotyphosa, and
Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 12, No. 3, March 2006 501
*Purdue University, West Lafayette, Indiana, USA; and †VCA
Antech, Los Angeles, California, USAPomona (Figure 1). No consistent or distinct geographic
pattern for positive MAT results was observed in the study
(Figure 2), but seropositivity was greater in the midwest,
south-central, and northwest regions of the United States.
Moderately strong positive correlation in seropositivity
(r, 0.59–0.72) was present between serovars Autumnalis,
Pomona, Grippotyphosa, and Bratislava, with the strongest
correlation between serovars Autumnalis and Pomona. In
contrast, weak positive correlation (r = 0.36) was found
between serovars Canicola and Icterohaemorrhagiae, and
each of these serovars was weakly correlated (r, 0.20– 0.33)
with serovars Autumnalis, Pomona, Grippotyphosa, and
Bratislava. All rank correlation coefficients were signifi-
cant at p<0.0001. Serovar Hardjo was excluded from cor-
relation analysis because of the small number of positive
test results.
Conclusions
Positive leptospirosis MAT results in dogs may indicate
natural infection due to direct or indirect contact with
wildlife maintenance hosts or recent vaccination (2).
However, titers >800 from vaccination are considered
unlikely as postvaccinal titers wane rapidly (10) and most
leptospiral bacterins available for dogs are bivalent for
Canicola and Icterohaemorrhagiae, 2 serovars with low
seropositivity in this study. Although the health and vacci-
nation status of dogs from which sera were submitted was
unknown, veterinarians most likely submitted samples for
leptospirosis testing when they suspected leptospirosis
based on clinical signs including vomiting, fever, lethargy,
and anorexia.
The most common serovar associated with a positive
MAT result was Autumnalis, a serovar not currently
included in licensed canine bacterins. Reactivity to this
serovar in the MAT has been considered a possible para-
doxical cross-reaction with serovar Pomona (11); a strong
positive correlation in titers for these 2 serovars was found
in this study. The Autumnalis serovar has been isolated
from raccoons in the southern United States (12), and
seropositivity in dogs may represent natural infection from
this source. The MAT is not serovar-specific, but the 7
serovars evaluated in this study belong to different
serogroups (13). Serovar Grippotyphosa, the second most
common positive serovar in this study, has also been asso-
ciated with human leptospirosis outbreaks in the 1990s (8).  
The finding of a moderately high correlation in serolog-
ic reactivity between serovars Autumnalis, Pomona,
Grippotyphosa, and Bratislava suggests that cross-protec-
tion to Autumnalis could be induced by current bacterins
that lack this antigen. Canine vaccines are now available
with serovars Grippotyphosa and Pomona as well as the
traditional serovars Canicola and Icterohaemorrhagiae.
This vaccine may confer some immunity to serovar
Autumnalis, since some protein antigens are highly con-
served among several pathogenic serovars (14).
Limitations of the present study included the inability
to determine if multiple tests had been performed for indi-
vidual dogs, lack of data on clinical signs, and unknown
vaccination status of the dogs. The geographic distribution
of serologic reactivity during the study, however, indicates
broad dispersion of Leptospira pathogens that pose a risk
to both domestic animals and humans.
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Figure 1. Percentage of positive microscopic agglutination tests
by  Leptospira serovar, using 3 different cutoff titers for 23,005
canine sera from 2002 to 2004. Serovars Canicola and
Icterohaemorrhagiae have been used in canine bacterins for lep-
tospirosis during the study period. Ictero., Icterohaemorrhagiae;
Autumn., Autumnalis; Bratisl., Bratislava; Grippo., Grippotyphosa.Dogs in suburban or rural environments have been
shown to be at increased risk of leptospirosis (15), presum-
ably because of greater likelihood of contact with wildlife
habitats. Dogs may be sentinels for human exposure to this
zoonotic organism. Veterinary practitioners and public
health officials need to be aware of the potential change in
the ecologic environment and circulating endemic strains
for this zoonotic organism.
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Figure 2. Canine leptospirosis microscopic agglutination test
results shown as the percentage positive and standard error, by
state and year from 2002 to 2004. A test was considered positive
if the titer for any serovar was >400 for Autumnalis, Bratislava,
Canicola, Grippotyphosa, Icterohaemorrhagiae, Pomona, or
Hardjo serovars.